Marshall Wace
FRLN

Marshall Wace’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Marshall Wace’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,379
Closed -$218K – 4213
2021
Q4 		$218K Sell
7,379
-16,363
-69% -$668K ﹤0.01% 3132
2021
Q3 		$1.23M Buy
+23,742
New +$1.69M 0.01% 1893

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Marshall Wace's FRLN Position: Q1 2022 in Review

Marshall Wace sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 7,379 shares — an estimated $218K sold.

Marshall Wace first reported a position in FRLN in Q3 2021 and held it in 2 quarters. The position peaked at $1.23M in Q3 2021. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

  • Marshall Wace reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 7,379 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $218K.
  • Marshall Wace first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 2 quarters.
  • Marshall Wace's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $1.23M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.